• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄糖依赖性促胰岛素多肽在1型糖尿病男性患者稳定基础胰岛素替代及高血糖期间诱导脂肪分解:一项随机、双盲、安慰剂对照、交叉临床试验。

Glucose-dependent insulinotropic polypeptide induces lipolysis during stable basal insulin substitution and hyperglycaemia in men with type 1 diabetes: A randomized, double-blind, placebo-controlled, crossover clinical trial.

作者信息

Heimburger Sebastian M N, Nielsen Chris N, Calanna Salvatore, Holst Jens J, Vilsbøll Tina, Knop Filip K, Christensen Mikkel B

机构信息

Centre for Clinical Metabolic Research, Copenhagen University Hospital - Herlev and Gentofte, Hellerup, Denmark.

Steno Diabetes Centre Copenhagen, Gentofte, Denmark.

出版信息

Diabetes Obes Metab. 2022 Jan;24(1):142-147. doi: 10.1111/dom.14545. Epub 2021 Sep 20.

DOI:10.1111/dom.14545
PMID:34490741
Abstract

Glucose-dependent insulinotropic polypeptide (GIP) plays an important role in the glucose and lipid metabolism. We investigated the effects of exogenous GIP on lipid metabolism during time of stable insulin levels. Ten male patients with type 1 diabetes without endogenous insulin secretion (C-peptide-negative, mean [±SD] age 26 ± 4years, body mass index 24 [±2] kg/m , glycated haemoglobin 56 [±8] mmol/mol or 7.3 [±0.8]%) were studied in a randomized, double-blind, placebo-controlled, crossover study with continuous intravenous infusions of GIP (4 pmol/kg/min) or placebo (saline), during two separate 90-minute hyperglycaemic (12 mmol/L) clamps with basal insulin substitution (0.1-0.2 mU/kg/min). Plasma glycerol concentrations increased from baseline during GIP infusion and decreased during placebo infusion (baseline-subtracted area under the curve [bsAUC] 703 ± 407 vs. -262 ± 240 μmol/L × min, respectively; P < 0.001). Free fatty acids (FFAs) increased during GIP infusions (bsAUC 5505 ± 2170 μEq/L × min) and remained unchanged during placebo infusion (bsAUC -74 ± 2363 μEq/L × min), resulting in a significant difference between GIP and placebo infusions (P < 0.001). Plasma concentrations of glucose, insulin, glucagon-like peptide-1 and glucagon were similar during GIP and placebo infusions. GIP increased plasma glycerol and FFAs in patients with type 1 diabetes during hyperglycaemia and stable basal insulin levels. This supports a direct lipolytic effect of GIP at high glucose and low levels of plasma insulin.

摘要

葡萄糖依赖性促胰岛素多肽(GIP)在葡萄糖和脂质代谢中起重要作用。我们研究了在胰岛素水平稳定期间外源性GIP对脂质代谢的影响。在一项随机、双盲、安慰剂对照、交叉研究中,对10名无内源性胰岛素分泌的1型糖尿病男性患者(C肽阴性,平均[±标准差]年龄26±4岁,体重指数24[±2]kg/m²,糖化血红蛋白56[±8]mmol/mol或7.3[±0.8]%)进行了研究,在两次单独的90分钟高血糖(12 mmol/L)钳夹期间,持续静脉输注GIP(4 pmol/kg/min)或安慰剂(生理盐水),同时进行基础胰岛素替代(0.1 - 0.2 mU/kg/min)。在输注GIP期间,血浆甘油浓度从基线升高,而在输注安慰剂期间降低(曲线下面积减去基线[bsAUC]分别为703±407与 - 262±240 μmol/L×min;P < 0.001)。在输注GIP期间游离脂肪酸(FFAs)增加(bsAUC 5505±2170 μEq/L×min),而在输注安慰剂期间保持不变(bsAUC - 74±2363 μEq/L×min),导致GIP和安慰剂输注之间存在显著差异(P < 0.001)。在输注GIP和安慰剂期间,血浆葡萄糖、胰岛素、胰高血糖素样肽 - 1和胰高血糖素的浓度相似。在高血糖和基础胰岛素水平稳定的1型糖尿病患者中,GIP增加了血浆甘油和FFAs。这支持了GIP在高血糖和低血浆胰岛素水平时的直接脂解作用。

相似文献

1
Glucose-dependent insulinotropic polypeptide induces lipolysis during stable basal insulin substitution and hyperglycaemia in men with type 1 diabetes: A randomized, double-blind, placebo-controlled, crossover clinical trial.葡萄糖依赖性促胰岛素多肽在1型糖尿病男性患者稳定基础胰岛素替代及高血糖期间诱导脂肪分解:一项随机、双盲、安慰剂对照、交叉临床试验。
Diabetes Obes Metab. 2022 Jan;24(1):142-147. doi: 10.1111/dom.14545. Epub 2021 Sep 20.
2
The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.6 天皮下葡萄糖依赖性胰岛素多肽输注对 1 型糖尿病患者血糖范围内时间的影响:一项随机、双盲、安慰剂对照交叉试验。
Diabetologia. 2021 Nov;64(11):2425-2431. doi: 10.1007/s00125-021-05547-8. Epub 2021 Aug 17.
3
GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals.健康个体进餐后的 GIP 和 GLP-1 受体拮抗作用。
J Clin Endocrinol Metab. 2020 Mar 1;105(3). doi: 10.1210/clinem/dgz175.
4
Effects of endogenous GIP in patients with type 2 diabetes.2 型糖尿病患者内源性 GIP 的作用。
Eur J Endocrinol. 2021 May 21;185(1):33-45. doi: 10.1530/EJE-21-0135.
5
GIP(3-30)NH is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study.GIP(3-30)NH 是一种有效的人类 GIP 受体拮抗剂:一项随机、双盲、安慰剂对照、交叉研究。
Diabetologia. 2018 Feb;61(2):413-423. doi: 10.1007/s00125-017-4447-4. Epub 2017 Sep 25.
6
Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.葡萄糖依赖性促胰岛素多肽:对人体胰岛素和胰高血糖素分泌的影响
Dan Med J. 2016 Apr;63(4).
7
Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.葡萄糖依赖性胰岛素多肽增强 1 型糖尿病患者低血糖时胰高血糖素的反应。
Diabetes. 2015 Jan;64(1):72-8. doi: 10.2337/db14-0440. Epub 2014 Jul 22.
8
Endogenous Glucose-Dependent Insulinotropic Polypeptide Contributes to Sitagliptin-Mediated Improvement in β-Cell Function in Patients With Type 2 Diabetes.内源性葡萄糖依赖性胰岛素促分泌多肽有助于西格列汀改善 2 型糖尿病患者的β细胞功能。
Diabetes. 2022 Oct 1;71(10):2209-2221. doi: 10.2337/db22-0059.
9
Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.危重症期间葡萄糖依赖性促胰岛素多肽对胃排空、血糖和胰岛素血症的影响:一项前瞻性、双盲、随机、交叉研究。
Crit Care. 2015 Jan 23;19(1):20. doi: 10.1186/s13054-014-0718-3.
10
Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes.葡萄糖依赖性胰岛素促泌肽:2 型糖尿病患者的血糖稳定作用。
J Clin Endocrinol Metab. 2014 Mar;99(3):E418-26. doi: 10.1210/jc.2013-3644. Epub 2013 Dec 11.

引用本文的文献

1
Glucose-dependent insulinotropic polypeptide (GIP).葡萄糖依赖性促胰岛素多肽(GIP)。
Mol Metab. 2025 May;95:102118. doi: 10.1016/j.molmet.2025.102118. Epub 2025 Feb 28.
2
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes.基于双重和三重肠促胰岛素的共激动剂:肥胖症和糖尿病的新型疗法。
Diabetes Ther. 2024 May;15(5):1069-1084. doi: 10.1007/s13300-024-01566-x. Epub 2024 Apr 4.
3
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don't.基于肠促胰岛素的多重作用的药理学进展:我们所知与未知
Physiology (Bethesda). 2024 May 1;39(3):142-156. doi: 10.1152/physiol.00032.2023. Epub 2024 Feb 14.
4
Glucose-Dependent Insulinotropic Polypeptide Plasma Level Influences the Effect of n-3 PUFA Supplementation.葡萄糖依赖性促胰岛素多肽血浆水平影响n-3多不饱和脂肪酸补充的效果。
Diagnostics (Basel). 2022 Aug 16;12(8):1984. doi: 10.3390/diagnostics12081984.
5
Tirzepatide: A Novel, Once-weekly Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes.替尔泊肽:一种新型的每周一次的双重GIP和GLP-1受体激动剂,用于治疗2型糖尿病。
touchREV Endocrinol. 2022 Jun;18(1):10-19. doi: 10.17925/EE.2022.18.1.10. Epub 2022 Jun 16.